Global Apheresis Market

Global Apheresis Market Size, Share, Growth Analysis, By Device(Leukapheresis, plasmapheresis), By Technology(Centrifugation and membrane separation), By Application(Renal disorders, hematological disorders) - Industry Forecast 2023-2030


Report ID: SQMIG35D2190 | Region: Global | Published Date: February, 2024 | Pages: 157 | Tables: 92 | Figures: 76

Global Apheresis Market Insights

Apheresis Market size was valued at USD 2.10 billion in 2021 and is poised to grow from USD 2.79 billion in 2022 to USD 6.5 billion by 2030, at a CAGR of 11.15% during the forecast period (2023-2030).

The apheresis market is experiencing significant growth, driven by several factors. Firstly, the increasing burden of diseases and the rising demand for safe blood components are propelling the market forward.

Additionally, technological advancements in apheresis techniques are facilitating the development of new and improved procedures. Moreover, the implementation of favorable reimbursement policies and increased funding for apheresis procedures are supporting market growth.

Apheresis is increasingly being used as a primary or adjunct therapy for various diseases, including thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, drug toxicities, autoimmune diseases, sepsis, and fulminant hepatic failure. The versatility and efficacy of apheresis procedures contribute to their rising adoption in clinical settings.

Furthermore, product innovations and approvals play a significant role in driving market growth. Despite the positive growth prospects, the market faces certain challenges such as a shortage of skilled professionals, concerns related to blood contamination, and the associated costs of apheresis procedures. Overcoming these barriers will be crucial for sustaining the market's growth trajectory.

US Apheresis Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2023-2030

Global Market Size

USD 2.10 billion

Largest Segment

centrifugation

Growth Rate

11.15% CAGR

Global Apheresis Market ($ Bn)
Country Share for North America Region (%)
Global Apheresis Market By technology ($ Bn)

To get more reports on the above market click here to Buy The Report

Global Apheresis Market Segmental Analysis

The global apheresis market is segmented on the basis of product, technology, application, and region. The apheresis market can be categorized based on product, such as devices and disposables, as well as different apheresis procedures, including leukapheresis, plasmapheresis, plateletpheresis, erythrocytapheresis, and other apheresis procedures. The market is also classified by technology, such as centrifugation and membrane separation. Additionally, the application of apheresis extends to renal disorders, hematological disorders, neurological disorders, autoimmune disorders, and other applications. Geographically, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America.

Apheresis Market Analysis By Product

The largest segment in the Apheresis market is plasmapheresis. The wide application of plasmapheresis in treating autoimmune disorders, neurological conditions, and certain hematological diseases contributes to its significant market size.

On the other hand, the fastest-growing segment in the apheresis market is leukapheresis. The growing demand for leukapheresis is driven by the increasing adoption of cellular therapies, such as CAR-T cell therapy. The expanding use of cellular therapies in treating cancer and other diseases fuels the demand for leukapheresis procedures, making it the fastest-growing segment in the market.

Apheresis Market Analysis By Technology

The largest segment in the apheresis market based on technology is centrifugation. Centrifugation is a well-established and widely used technology in apheresis procedures. The reliability, versatility, and established track record of centrifugation technology contribute to its dominant market position.

The fastest-growing segment in the apheresis market in terms of technology is membrane separation. The growing demand for targeted therapies and the need for more gentle and efficient blood component separation techniques drive the increasing adoption of membrane separation in apheresis procedures. The ability of membrane separation technology to achieve high-quality separation and improved patient outcomes positions it as the fastest-growing segment in the market.

Global Apheresis Market By technology, 2021 (%)

To get detailed analysis on other segments, Request For Sample Report

Global Apheresis Market Regional Insights

The dominating region in the global apheresis market is North America. North America boasts a significant market share due to several factors. The region has a well-established healthcare infrastructure, advanced technological capabilities, and a high prevalence of chronic diseases that require apheresis procedures. Moreover, favorable reimbursement policies and strong awareness about the benefits of apheresis therapies contribute to the region's dominance. North America is home to key market players, cutting-edge research facilities, and a supportive regulatory framework, all of which further drive the market's growth in the region. These factors combined make North America the leading and dominating region in the global apheresis market.

The fastest-growing region in the global apheresis market is Asia-Pacific. Asia-Pacific is experiencing remarkable growth in the market due to various factors. The region has a large and rapidly aging population, which increases the incidence of chronic diseases that require apheresis procedures. Additionally, rising healthcare expenditure, improving healthcare infrastructure, and increasing awareness about advanced treatment options are propelling the demand for apheresis therapies in the region. Moreover, the presence of a large patient pool, particularly in countries like China and India, presents significant growth opportunities. As a result, Asia-Pacific is witnessing substantial investments, collaborations, and product launches by key market players to capitalize on the growing market potential. With its expanding healthcare sector and untapped market opportunities, Asia-Pacific is positioned as the fastest-growing region in the global apheresis market.

Global Apheresis Market By Geography, 2023-2030
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Apheresis Market Dynamics

Apheresis Market Drivers

Increasing Prevalence Of Chronic Diseases

  • The rising incidence of chronic diseases such as cancer, autoimmune disorders, and cardiovascular diseases is driving the demand for apheresis procedures. Apheresis plays a crucial role in managing these conditions by selectively removing or collecting specific blood components, thereby improving patient outcomes.
  • There is a shift towards personalized medicine, where treatments are tailored to individual patient characteristics. Apheresis procedures enable targeted therapies by selectively removing disease-causing substances or collecting specific blood components for further treatment or research, aligning with the principles of personalized medicine.

Apheresis Market Restraints

High Cost

  • The high cost associated with apheresis devices and therapeutic procedures, along with the challenges of installing these devices, pose obstacles to the growth of the apheresis market. The significant investment required for acquiring and maintaining apheresis devices, as well as the expenses associated with conducting therapeutic apheresis procedures, can limit their widespread adoption. Additionally, the lack of awareness about apheresis among potential blood donors may result in fewer blood donations using apheresis techniques, further hindering market growth.

Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report

Global Apheresis Market Competitive Landscape

The market is moderately competitive, with a few major players dominating the industry. While the market has established a strong presence in many regions and demonstrated initial success, its full potential in developing regions is yet to be fully realized. The growth of the market is being propelled by increasing government initiatives and a rising awareness among people about the condition. This heightened awareness is driving the demand for advanced treatments and therapies in the market.

Apheresis Market Top Player’s Company Profiles

  • B. Braun SE (Germany)
  • Asahi Kasei Corporation (Japan)
  • Fresenius SE & Co. KGAA (Germany)
  • Terumo Corporation (Terumo BCT Inc.) (Japan)
  • Grifols (Spain)
  • CSL Behring (Australia)
  • Octapharma (Switzerland)
  • Kedrion (Italy)
  • Pfizer Inc. (United States)
  • Baxter International Inc. (United States)
  • Bayer AG (Germany)
  • BioMarin Pharmaceutical Inc. (United States)
  • Roche (Chugai Pharmaceutical Co.) (Switzerland/Japan)
  • Sanofi (France)
  • Takeda Pharmaceutical (Japan)
  • Novo Nordisk (Denmark)
  • Biogen (United States)
  • Shire (Ireland)
  • Grifols (Spain)
  • Kogenate (Germany)

Apheresis Market Recent Developments

  • In July 2022, Terumo Blood and Cell Technologies entered into a collaboration with Eliaz Therapeutics to develop and commercialize a groundbreaking therapeutic apheresis treatment specifically designed for acute kidney injury (AKI).
  • In June 2022, Terumo Blood and Cell Technologies announced a significant milestone in the treatment of sickle cell disease. The UK's NHS England selected Terumo's Spectra Optia Apheresis System for the automated red blood cell exchange (RBCX) procedure as part of the NHS MedTech Funding Mandate (MTFM) program.

Global Apheresis Key Market Trends

  • One key market trend in the apheresis market is the increasing adoption of personalized medicine and targeted therapies. As healthcare advancements continue to evolve, there is a growing emphasis on tailoring treatments to individual patients based on their specific medical conditions, genetic profiles, and treatment responses. This approach allows for precise and customized treatment regimens, optimizing therapeutic outcomes and improving patient care.

Global Apheresis Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Deployment mode team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our analyses, the apheresis market analysis reveals a positive growth trajectory driven by various factors. The increasing prevalence of chronic diseases, rising demand for personalized medicine, and advancements in apheresis technologies are key drivers of market expansion. The market is witnessing a shift towards targeted therapies and precision medicine, allowing for tailored treatment plans based on individual patient characteristics. Additionally, the development of advanced devices and automation in apheresis procedures enhances efficiency and safety. Ongoing research and development activities explore new therapeutic areas and expand the applications of apheresis therapies.

Report Metric Details
Market size value in 2021 USD 2.10 billion
Market size value in 2030 USD 6.5 billion
Growth Rate 11.15%
Base year 2021
Forecast period 2023-2030
Forecast Unit (Value) USD Billion
Segments covered
  • Device
    • Leukapheresis, plasmapheresis, plateletpheresis, erythrocytapheresis, and other apheresis procedures
  • Technology
    • Centrifugation and membrane separation
  • Application
    • Renal disorders, hematological disorders, neurological disorders, autoimmune disorders, and other applications
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • B. Braun SE (Germany)
  • Asahi Kasei Corporation (Japan)
  • Fresenius SE & Co. KGAA (Germany)
  • Terumo Corporation (Terumo BCT Inc.) (Japan)
  • Grifols (Spain)
  • CSL Behring (Australia)
  • Octapharma (Switzerland)
  • Kedrion (Italy)
  • Pfizer Inc. (United States)
  • Baxter International Inc. (United States)
  • Bayer AG (Germany)
  • BioMarin Pharmaceutical Inc. (United States)
  • Roche (Chugai Pharmaceutical Co.) (Switzerland/Japan)
  • Sanofi (France)
  • Takeda Pharmaceutical (Japan)
  • Novo Nordisk (Denmark)
  • Biogen (United States)
  • Shire (Ireland)
  • Grifols (Spain)
  • Kogenate (Germany)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Apheresis Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Apheresis Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Apheresis Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Apheresis Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Apheresis Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Apheresis Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

SPEAK TO AN ANALYST

FAQ's

Apheresis Market size was valued at USD 2.10 billion in 2021 and is poised to grow from USD 2.79 billion in 2022 to USD 6.5 billion by 2030, at a CAGR of 11.15% during the forecast period (2023-2030).

The market is moderately competitive, with a few major players dominating the industry. While the market has established a strong presence in many regions and demonstrated initial success, its full potential in developing regions is yet to be fully realized. The growth of the market is being propelled by increasing government initiatives and a rising awareness among people about the condition. This heightened awareness is driving the demand for advanced treatments and therapies in the market. 'B. Braun SE (Germany)', 'Asahi Kasei Corporation (Japan)', 'Fresenius SE & Co. KGAA (Germany)', 'Terumo Corporation (Terumo BCT Inc.) (Japan)', 'Grifols (Spain)', 'CSL Behring (Australia)', 'Octapharma (Switzerland)', 'Kedrion (Italy)', 'Pfizer Inc. (United States)', 'Baxter International Inc. (United States)', 'Bayer AG (Germany)', 'BioMarin Pharmaceutical Inc. (United States)', 'Roche (Chugai Pharmaceutical Co.) (Switzerland/Japan)', 'Sanofi (France)', 'Takeda Pharmaceutical (Japan)', 'Novo Nordisk (Denmark)', 'Biogen (United States)', 'Shire (Ireland)', 'Grifols (Spain)', 'Kogenate (Germany)'

The rising incidence of chronic diseases such as cancer, autoimmune disorders, and cardiovascular diseases is driving the demand for apheresis procedures. Apheresis plays a crucial role in managing these conditions by selectively removing or collecting specific blood components, thereby improving patient outcomes.

One key market trend in the apheresis market is the increasing adoption of personalized medicine and targeted therapies. As healthcare advancements continue to evolve, there is a growing emphasis on tailoring treatments to individual patients based on their specific medical conditions, genetic profiles, and treatment responses. This approach allows for precise and customized treatment regimens, optimizing therapeutic outcomes and improving patient care.

The dominating region in the global apheresis market is North America. North America boasts a significant market share due to several factors. The region has a well-established healthcare infrastructure, advanced technological capabilities, and a high prevalence of chronic diseases that require apheresis procedures. Moreover, favorable reimbursement policies and strong awareness about the benefits of apheresis therapies contribute to the region's dominance. North America is home to key market players, cutting-edge research facilities, and a supportive regulatory framework, all of which further drive the market's growth in the region. These factors combined make North America the leading and dominating region in the global apheresis market.

Speak With Our Analyst

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Apheresis Market

Product ID: SQMIG35D2190

$5,300
BUY NOW GET SAMPLE